ArticlePharmaceutical research2012
Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.
Sandra Reichstetter et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it